Menopause Sleep Disorders In The Postmenopausal Period clinical trials

Explore recruiting menopause sleep disorders in the postmenopausal period clinical trials.

Also recruiting in Europe

Menopause Sleep Disorders In The Postmenopausal Period trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, double-blind, placebo-controlled, multicenter study evaluating the effect of a 12-week DHEA combination of 20 mg and 2 mg prolonged-release melatonin on sleep quality and mood in postmenopausal women.

Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Menopause Sleep Disorders In The Postmenopausal Period trials by city

Menopause Sleep Disorders In The Postmenopausal Period in Toronto Menopause Sleep Disorders In The Postmenopausal Period in Vancouver Menopause Sleep Disorders In The Postmenopausal Period in Montreal Menopause Sleep Disorders In The Postmenopausal Period in Calgary Menopause Sleep Disorders In The Postmenopausal Period in Edmonton Menopause Sleep Disorders In The Postmenopausal Period in Ottawa Menopause Sleep Disorders In The Postmenopausal Period in Winnipeg Menopause Sleep Disorders In The Postmenopausal Period in Quebec City Menopause Sleep Disorders In The Postmenopausal Period in Hamilton Menopause Sleep Disorders In The Postmenopausal Period in Kitchener Menopause Sleep Disorders In The Postmenopausal Period in London Menopause Sleep Disorders In The Postmenopausal Period in Halifax Menopause Sleep Disorders In The Postmenopausal Period in New York Menopause Sleep Disorders In The Postmenopausal Period in Los Angeles Menopause Sleep Disorders In The Postmenopausal Period in Chicago Menopause Sleep Disorders In The Postmenopausal Period in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease